Financial Summary for Fiscal Year Ending March 2026 [IFRS] (Consolidated)

Overview of Financial Performance

For the fiscal year ending March 2026, consolidated results were driven by significant expansion in demand for testers for high-performance semiconductors related to AI. Net sales reached ¥1,128.6 billion (up 44.7% YoY), and operating income was ¥499.1 billion (up 118.8% YoY), both setting record highs. Profit before tax was ¥516.7 billion (up 129.9% YoY), while net income attributable to owners of parent was ¥375.4 billion (up 132.9% YoY). By segment, the Test System Business performed strongly with net sales of ¥1,019.4 billion (up 49.3% YoY) and segment profit of ¥518.8 billion (up 97.9% YoY). The Services and Other segment also recovered with net sales of ¥109.2 billion (up 12.7% YoY) and segment profit of ¥8.8 billion.

Financial Position and Cash Flow Overview

Total assets increased by ¥317.6 billion year-over-year to ¥1,171.8 billion, and total liabilities increased by ¥28.4 billion to ¥376.1 billion. The equity ratio attributable to owners of parent rose to 67.9%. Cash flows from operating activities resulted in an inflow of ¥335.2 billion, investing activities used ¥34.6 billion, and financing activities used ¥230.6 billion. Cash and cash equivalents at the end of the period increased to ¥339.9066 billion.

Outlook

For the fiscal year ending March 2027, consolidated earnings forecasts project net sales of ¥1,420.0 billion (up 25.8% YoY), operating income of ¥627.5 billion (up 25.7% YoY), profit before tax of ¥629.0 billion (up 21.7% YoY), and net income of ¥465.5 billion (up 24.0% YoY). The semiconductor tester market is expected to reach a record scale, driven by expansion in the AI-related semiconductor market. Meanwhile, geopolitical risks and supply chain challenges warrant close attention, and efforts will continue to strengthen supply chain resilience.

Capital Policy Overview

On April 20, 2026, Advantest issued ¥100 billion of Euro Yen Convertible Bonds with Stock Acquisition Rights due 2031. The proceeds will be allocated to expanding production capacity for semiconductor testers, securing strategic inventory, and developing next-generation test solutions. Additionally, the number of treasury shares decreased through share buybacks, aiming to improve capital efficiency.